SAC Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
BIT
BFA
SAC Capital Advisors's AMGN Position: Q2 2014 in Review
SAC Capital Advisors sold out of Amgen (AMGN) in Q2 2014, closing a stake of 13,665 shares — an estimated $1.69M sold.
SAC Capital Advisors first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $85.7M in Q4 2013. 1,185 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.
- SAC Capital Advisors reported no remaining Amgen position as of Q2 2014 after selling out during the quarter.
- SAC Capital Advisors sold 13,665 Amgen shares in Q2 2014, an estimated $1.69M.
- SAC Capital Advisors first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
- SAC Capital Advisors's Amgen position peaked at $85.7M in Q4 2013.
- 1,185 funds tracked by Wall St. Rank held Amgen as of Q2 2014.
Based on SAC Capital Advisors's 13F filing for Q2 2014.